Key facts
- It has raised $1.0M; the latest was Early Stage VC ($1.0M) in Sep 2025.
- Notable investors include Altitude Capital, Askeladden & Co, Snefred Invest.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Journalia
- ·The full record, as it builds
Funding rounds
No funding rounds for Journalia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Journalia
Provider of automated documentation tools designed for clinical consultation support. The company's platform transcribes spoken interactions into structured medical notes in real time, adapts to professional-specific terminology, and continuously updates its transcription capabilities, enabling healthcare practitioners to improve focus during patient engagement, reduce administrative workload, and achieve more consistent and accurate record-keeping across various medical disciplines.
- Sector
- Healthcare
- HQ
- Norway
- Founded
- 2025
- Website
- journalia.no/
- Ownership
- Privately Held (backing)
Journalia doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Journalia shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Journalia in its N-PORT filings yet. We sweep new filings monthly.